Wahlström T, Lindgren J, Korhonen M, Seppälä M
Lancet. 1979 Dec 1;2(8153):1159-60. doi: 10.1016/s0140-6736(79)92386-9.
The differential diagnosis of endocervical and endometrial adenocarcinomas can be improved by the demonstration of carcinoembryonic antigen (CEA) in tissue by means of immunoperoxidase staining. Tissue from 131 (80%) of 163 patients with endocervical adenocarcinoma but only 11 (8%) of 137 patients with endometrial adenocarcinoma was CEA-positive. The commonest exceptions were endocervical mesonephroid adenocarcinomas (which were CEA-negative) and endometrial adenosquamous carcinomas (which were CEA-positive). After exclusion of these on simple morphological criteria, 86 of 107 endocervical adenocarcinomas (80%) were CEA-positive, and all 122 endometrial adenocarcinomas were CEA-negative. The remarkable difference in the expression of CEA between endocervical and endometrial adenocarcinomas suggests a novel application of immunohistochemistry in routine clinical practice.
通过免疫过氧化物酶染色法在组织中显示癌胚抗原(CEA),可改善宫颈内膜腺癌和子宫内膜腺癌的鉴别诊断。163例宫颈内膜腺癌患者中的131例(80%)组织CEA呈阳性,而137例子宫内膜腺癌患者中只有11例(8%)组织CEA呈阳性。最常见的例外情况是宫颈中肾样腺癌(CEA阴性)和子宫内膜腺鳞癌(CEA阳性)。根据简单的形态学标准排除这些病例后,107例宫颈内膜腺癌中的86例(80%)CEA呈阳性,而所有122例子宫内膜腺癌CEA均为阴性。宫颈内膜腺癌和子宫内膜腺癌之间CEA表达的显著差异提示免疫组化在常规临床实践中的新应用。